−0.17USD
−8.57 MUSD
1.00 MUSD
46.48 M
About MediciNova, Inc.
Sector
CEO
Yuichi Iwaki
Headquarters
La Jolla
Website
Employees (FY)
13
Founded
2000
ISIN
US58468P2065
FIGI
BBG000RDP030
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. The company was founded by Yuichi Iwaki on September 26, 2000, and is headquartered in La Jolla, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MNOV is 1.39 USD — it has decreased by 0.71% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MediciNova, Inc. stocks are traded under the ticker MNOV.
MediciNova, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
MNOV stock is 1.44% volatile and has beta coefficient of 0.06. Check out the list of the most volatile stocks — is MediciNova, Inc. there?
One year price forecast for MediciNova, Inc. has a max estimate of 28.00 USD and a min estimate of 28.00 USD.
MNOV earnings for the last quarter are −0.01 USD per share, whereas the estimation was −0.08 USD resulting in a 87.50% surprise. The estimated earnings for the next quarter are −0.08 USD per share. See more details about MediciNova, Inc. earnings.
Yes, you can track MediciNova, Inc. financials in yearly and quarterly reports right on TradingView.
MNOV stock has fallen by 13.13% compared to the previous week, the month change is a 4.51% rise, over the last year MediciNova, Inc. has showed a 36.82% decrease.
MNOV net income for the last quarter is −2.06 M USD, while the quarter before that showed −723.11 K USD of net income which accounts for −184.76% change. Track more MediciNova, Inc. financial stats to get the full picture.
No, MNOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MNOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MediciNova, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 13.00 employees. See our rating of the largest employees — is MediciNova, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MediciNova, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MediciNova, Inc. stock shows the sell signal. See more of MediciNova, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MediciNova, Inc. future price: according to them, MNOV price has a max estimate of 28.00 USD and a min estimate of 28.00 USD. Read a more detailed MediciNova, Inc. forecast: see what analysts think of MediciNova, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MediciNova, Inc. EBITDA is −9.78 M USD, and current EBITDA margin is −988.00%. See more stats in MediciNova, Inc. financial statements.